Ellex Medical Lasers Limited provided earnings guidance for the six months ended December 31, 2014. For the period, the company expected to report an operating profit of about $1.3 million. The result will be a material increase from $654,000 reported for the December 2013 half-year.

Group revenue is expected to be $31 million, a $5 million or 19% increase compared with the prior corresponding period. The increase in revenue is primarily attributable to strong sales globally of the company's new Ultra Q Reflex laser, which is for the treatment of vitreous floaters, initial sales of the new Integre Pro retinal laser, the lower value of the Australian dollar against the US dollar, the acquisition of the Canaloplasty glaucoma surgery business and generally increased sales demand in Australia and Asia.